Rain Therapeutics Inc. (RAIN)

Jan 26, 2024 - RAIN was delisted (reason: acquired by Pathos AI)
1.210
-0.020 (-1.63%)
Last trade price
Market Cap 44.01M
Revenue (ttm) n/a
Net Income (ttm) -72.26M
Shares Out 45.18M
EPS (ttm) -2.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close 1.230
Day's Range 1.210 - 1.270
52-Week Range 0.820 - 11.320
Beta 0.27
Analysts Buy
Price Target 6.87 (+467.77%)
Earnings Date Mar 7, 2024

About RAIN

As of January 26, 2024, operates as a subsidiary of Pathos AI, Inc. [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Apr 23, 2021
Employees 63
Stock Exchange NASDAQ
Ticker Symbol RAIN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for RAIN stock is "Buy." The 12-month stock price forecast is $6.87, which is an increase of 467.77% from the latest price.

Price Target
$6.87
(467.77% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Pathos AI Completes Acquisition of Rain Oncology

CHICAGO--(BUSINESS WIRE)--Pathos AI, Inc. (“Pathos”) today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. (“Merger Sub”), successfully completed its tender offer to acq...

2 months ago - Business Wire

RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Rain Oncology In...

3 months ago - Business Wire

Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos

MILWAUKEE , Dec. 14, 2023 /PRNewswire/ -- Ademi LLP is investigating Rain (NASDAQ: RAIN) for possible breaches of fiduciary duty and other violations of law in its transaction with Pathos. Click here ...

3 months ago - PRNewsWire

RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Rain Oncology Inc. (NASDAQ: RAIN) to Pathos AI, Inc. for $1.16 in cash per share plus a n...

3 months ago - Business Wire

Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights

NEWARK, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”), today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. (“Pathos”) will ...

3 months ago - GlobeNewsWire

Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

NEWARK, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NasdaqGS: RAIN) (Rain) today reported financial results for the third quarter ended September 30, 2023, along with an update on th...

5 months ago - GlobeNewsWire

Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences

NEWARK, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Rain Oncology, Inc. (NasdaqGS: RAIN) (“Rain”) confirmed that it has received an unsolicited proposal from Tang Capital, LP on behalf of Concentra Bios...

5 months ago - GlobeNewsWire

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)

NEW YORK , Sept. 12, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc..

7 months ago - PRNewsWire

ROSEN, A TOP RANKED LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN

NEW YORK , Sept. 11, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19...

7 months ago - PRNewsWire

SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit

NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities la...

7 months ago - Accesswire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming September 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of inve...

7 months ago - Business Wire

SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit

NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities la...

7 months ago - Accesswire

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Rain Investors of a Lead Plaintiff Deadline of September 12, 2023

NEW YORK , Sept. 11, 2023 /PRNewswire/ -- Attention Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behal...

7 months ago - PRNewsWire

RAIN Investors Have Opportunity to Lead Rain Oncology Inc. Securities Fraud Lawsuit

BENSALEM, Pa. , Sept. 8, 2023 /PRNewswire/ -- Law Offices of Howard G.

7 months ago - PRNewsWire

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Rain Oncology Inc.(RAIN) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , Sept. 7, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit.

7 months ago - PRNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN

NEW YORK , Sept. 5, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN).

7 months ago - PRNewsWire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN

NEW YORK , Sept. 4, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19,...

7 months ago - PRNewsWire

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN

NEW YORK , Aug. 28, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19,...

7 months ago - PRNewsWire

SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc.(RAIN) Shareholders

NEW YORK , Aug. 28, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Comp...

7 months ago - PRNewsWire

RAIN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Rain Oncology, Inc. and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Rain Oncology, Inc. (“Rai...

7 months ago - Business Wire

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RAIN

NEW YORK , Aug. 21, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19,...

7 months ago - PRNewsWire

RAIN LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Rain Oncology Inc.

NEW YORK, NY / ACCESSWIRE / August 18, 2023 / The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Rain Oncology Inc. ("Rain")...

8 months ago - Accesswire

RAIN LAWSUIT ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , Aug. 17, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFINITION:...

8 months ago - PRNewsWire

RAIN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. Shareholders

NEW YORK , Aug. 15, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Comp...

8 months ago - PRNewsWire

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Rain Investors of a Lead Plaintiff Deadline of September 12, 2023

NEW YORK , Aug. 14, 2023 /PRNewswire/ -- Attention Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf...

8 months ago - PRNewsWire